Article Per Year (5 Year)
p-Index From 2019 - 2024
0.23
P-Index
This Author published in this journals
All Journal Jurnal Kesehatan
Irfan Faisal Sjattar
Departemen Ilmu Anestesi, Universitas Hasanuddin Makassar
Health Professions Medicine & Pharmacology Nursing Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
COMPARISON OF TWO DIFFERENT DOSAGES OF COMBINATION OF INTRAVENOUS GRANISETRON WITH INTRAVENOUS DEXAMETHASONE AS A PROPHYLAXIS FOR NAUSEA AND VOMITING IN CAESAREAN SECTION WITH SUBARACHNOID BLOCK Irfan Faisal Sjattar; Syafruddin Gaus; Andi Salahuddin; Arifin Seweng
Jurnal Kesehatan Vol 15 No 1 (2022): JURNAL KESEHATAN
Publisher : Universitas Islam Negeri Alauddin Makassar

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24252/kesehatan.v15i1.25811

Abstract

Granisetron can be used to treat and prevent nausea and vomiting in patients receiving chemotherapy or radiotherapy, as well as during or after surgery. To compare the effects of two doses of intravenous granisetron on nausea and vomiting in Caesarean section with subarachnoid block. This study was a randomized double-blind clinical trial. Subjects were randomized into two groups: Granisetron 10 mcg/kg (GD10) and granisetron 25 mcg/kg (GD25). Dexamethasone 0.1 mg/kg was also administered to all subjects. A total of 21 subjects were included for each group. Data was analyzed using Mann Whitney U test. The results When comparing the incidence of nausea and vomiting in the GD10 and GD25 groups, there was a significant difference in the incidence of nausea (p = 0.001). In the GD10 group, there were nine participants who experienced nausea, whereas the GD25 group had none. Neither of the groups experienced vomiting, hence no additional therapy given to both groups. Granisetron is a selective 5-HT3 receptor antagonist and an effective antiemetic during and after neuraxial anesthesia for Caesarean section. The combination of granisetron and dexamethasone has been reported to be more potent than granisetron alone. Administration of granisetron 25 mcg/kg had a positive impact on patients, with no incidence of nausea and vomiting compared to administration of granisetron 10 mcg/kg.
Co-Authors Andi Salahuddin Arifin Seweng Syafruddin Gaus